{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fidpodcast.simplecast.com%2Fepisodes%2Fearly-hbv-treatment-7_P8_yDX","width":444,"version":"1.0","type":"rich","title":"How to Implement Earlier Hepatitis B Treatment","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/cde5c7f4-b051-4ec4-a919-ef38add847b5/cco-id-5673-hbv-early-pod2-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/1466a3fe-94d1-4e8d-90be-b0cfc8d0dcb1\" height=\"200\" width=\"100%\" title=\"How to Implement Earlier Hepatitis B Treatment\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Listen as Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, review strategies for more expansive HBV treatment while considering adverse events, cost-effectiveness, and patient perspectives. "}